As Some Pharma Companies Exit Facebook, Device Firms Stay Connected
This article was originally published in The Pink Sheet Daily
Although the new Facebook policy wasn't directed at medical device firms, some device companies have taken initiatives on their own to either closely monitor or, in some cases, delete all of the public comments on their Facebook walls
You may also be interested in...
House drafters’ dissatisfaction with FDA’s performance is evident in several provisions of draft user fee legislation. The agency would be required to finalize some guidances within a year of issuing a draft, which likely would provide more predictability for industry.
Certain drug classes will be required to submit certain types of ads, according to Tom Abrams, director of CDER’s recently elevated Office of Prescription Drug Promotion, but specifics will await the guidance itself.
Device and drug firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.